The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Interleukin-23: A key cytokine in inflammatory diseases
Open accessAbstract
Interleukin-23 (IL-23) is a pro-inflammatory cytokine composed of two subunits, p19 and p40. The p40 subunit is shared with IL-12. IL-23 and IL-12 have different receptors and different effects. Whereas IL-12 induces development of Th1 cells, which produce interferon-γ, IL-23 is involved in differentiation of Th17 cells in a pro-inflammatory context and especially in the presence of TGF-β and IL-6. Activated Th17 cells produce IL-17A, IL-17F, IL-6, IL-22, TNF-α, and GM-CSF. Inflammatory macrophages express IL-23R and are activated by IL-23 to produce IL-1, TNF-α, and IL-23 itself. These effects identify IL-23 as a central cytokine in autoimmunity and a highly promising treatment target for inflammatory diseases. IL-23 is found in the skin of patients with psoriasis, in the bowel wall of patients with chronic inflammatory bowel disease, and in synovial membrane of patients with rheumatoid arthritis. IL-23 is involved in osteoclastogenesis, independently from IL-17, via induction of RANKL expression. Debate continues to surround the role for IL-23 in the pathophysiology of inflammatory joint diseases (rheumatoid arthritis and spondyloarthritis). Ustekinumab, which inhibits IL-12 and IL-23 by blocking p40, has been found effective in cutaneous psoriasis and psoriatic arthritis, as well as in Crohn's disease. Treatments that specifically target IL-23 (antibodies to p19) are being developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Papp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
Buonocore, S., Ahern, P. P., Uhlig, H. H., Ivanov, I. I., Littman, D. R., Maloy, K. J., & Powrie, F. (2010) · Nature · doi:10.1038/nature08949 · Cited by 1,067
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Griffiths, C. E. M., Strober, B. E., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0810652 · Cited by 859
Anti–Interleukin-12 Antibody for Active Crohn's Disease
Mannon, P. J., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033402 · Cited by 848
Kastelein, R. A., Hunter, C. A., & Cua, D. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104758 · Cited by 763
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Differential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology
Uhlig, H. H., McKenzie, B. S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., Robinson, N., Buonocore, S., Tlaskalova-Hogenova, H., Cua, D. J., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.017 · Cited by 682
Gottlieb, A., Menter, A., Mendelsohn, A., Shen, Y.-K., Li, S., Guzzo, C., Fretzin, S., Kunynetz, R., & Kavanaugh, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60140-9 · Cited by 585
Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4
Watford, W. T., Hissong, B. D., Bream, J. H., Kanno, Y., Muul, L., & O'Shea, J. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00211.x · Cited by 572
Segal, B. M., Constantinescu, C. S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., & Kasper, L. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70173-x · Cited by 479
Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice
Elson, C. O., Cong, Y., Weaver, C. T., Schoeb, T. R., McClanahan, T. K., Fick, R. B., & Kastelein, R. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.104 · Cited by 453
Capon, F., Di Meglio, P., Szaub, J., Prescott, N. J., Dunster, C., Baumber, L., Timms, K., Gutin, A., Abkevic, V., Burden, A. D., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0397-0 · Cited by 408
DeLay, M. L., Turner, M. J., Klenk, E. I., Smith, J. A., Sowders, D. P., & Colbert, R. A. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24763 · Cited by 404
Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis
Palmer, G., Talabot‐Ayer, D., Lamacchia, C., Toy, D., Seemayer, C. A., Viatte, S., Finckh, A., Smith, D. E., & Gabay, C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24305 · Cited by 313
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
Yang, Y., Weiner, J., Liu, Y., Smith, A. J., Huss, D. J., Winger, R., Peng, H., Cravens, P. D., Racke, M. K., & Lovett-Racke, A. E. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082584 · Cited by 282
Petermann, F., Rothhammer, V., Claussen, M. C., Haas, J. D., Blanco, L. R., Heink, S., Prinz, I., Hemmer, B., Kuchroo, V. K., Oukka, M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.013 · Cited by 275
Interleukin‐35: odd one out or part of the family?
Collison, L. W., & Vignali, D. A. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00704.x · Cited by 260
Ciccia, F., Bombardieri, M., Principato, A., Giardina, A., Tripodo, C., Porcasi, R., Peralta, S., Franco, V., Giardina, E., Craxi, A., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24389 · Cited by 241
CCR6 is required for IL-23–induced psoriasis-like inflammation in mice
Hedrick, M. N., Lonsdorf, A. S., Shirakawa, A.-K., Lee, C.-C. R., Liao, F., Singh, S. P., Zhang, H. H., Grinberg, A., Love, P. E., Hwang, S. T., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37378 · Cited by 238
Town, T., Bai, F., Wang, T., Kaplan, A. T., Qian, F., Montgomery, R. R., Anderson, J. F., Flavell, R. A., & Fikrig, E. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.012 · Cited by 216
Kyttaris, V. C., Zhang, Z., Kuchroo, V. K., Oukka, M., & Tsokos, G. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903595 · Cited by 188
Liu, J., Cao, S., Herman, L. M., & Ma, X. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030026 · Cited by 187
The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis
Rueda, B., Orozco, G., Raya, E., Fernandez-Sueiro, J. L., Mulero, J., Blanco, F. J., Vilches, C., González-Gay, M. A., & Martin, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080283 · Cited by 166
Ito, Y., Usui, T., Kobayashi, S., Iguchi‐Hashimoto, M., Ito, H., Yoshitomi, H., Nakamura, T., Shimizu, M., Kawabata, D., Yukawa, N., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24687 · Cited by 162
Melis, L., Vandooren, B., Kruithof, E., Jacques, P., Vos, M. D., Mielants, H., Verbruggen, G., Keyser, F. D., & Elewaut, D. S. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.107649 · Cited by 156
Infection, inflammation, and chronic diseases: consequences of a modern lifestyle
Ehlers, S., & Kaufmann, S. H. E. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.02.003 · Cited by 140
Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis
Goff, B. L., Blanchard, F., Berthelot, J., Heymann, D., & Maugars, Y. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.03.002 · Cited by 99
Paneth cells: leukocyte-like mediators of innate immunity in the intestine
Keshav, S. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005556 · Cited by 99
Ustekinumab: Lessons Learned from Targeting Interleukin‐12/23p40 in Immune‐Mediated Diseases
Elliott, M., Benson, J., BLANK, M. A., Brodmerkel, C. M., Baker, D., Sharples, K. R., & Szapary, P. O. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05070.x · Cited by 95
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Longbrake, E. E., & Racke, M. K. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.3.319 · Cited by 79
What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells?
Bortoluci, K. R., Marinho, C. R. F., Barboza, R., Russo, M., Álvarez, J. M., & Lima, M. R. D. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.02.012 · Cited by 78
Gandhi, M. A., Alwawi, E. A., & Gordon, K. B. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.02.001 · Cited by 75
The clinical role of IL‐23p19 in patients with rheumatoid arthritis
Kim, H. ‐., Kim, H. ‐., Park, M.-W., Cho, M. ‐., Lee, S. ‐., & Kim, H. ‐. (2007) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740701286813 · Cited by 73
B Cell-Targeted Therapies for Systemic Lupus Erythematosus: An Update on Clinical Trial Data
Looney, R. J. (2010) · Drugs · doi:10.2165/11535420-000000000-00000 · Cited by 67
Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis
Hillyer, P., LARCHÉ, M. J., Bowman, E. P., McClanahan, T. K., Malefyt, R. D. W., Schewitz‐Bowers, L. P., Giddins, G. E. B., Feldmann, M., KASTELEIN, R. A., & Brennan, F. M. (2009) · Rheumatology · doi:10.1093/rheumatology/kep293 · Cited by 61
Cornelissen, F., Mus, A. M. C., Asmawidjaja, P. S., van Hamburg, J. P., Tocker, J. E., & Lubberts, E. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2893 · Cited by 54
Lima, X. T. V., Abuabara, K., Kimball, A. B., & Lima, H. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903092188 · Cited by 50
Triptolide Inhibits IL-12/IL-23 Expression in APCs via CCAAT/Enhancer-Binding Protein α
Zhang, Y., & Ma, X. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903417 · Cited by 48
Reconciling id, ego, and superego within interleukin‐23
Tato, C. M., & Cua, D. J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00715.x · Cited by 47
Hollis‐Moffatt, J. E., Merriman, M. E., Rodger, R. A., Rowley, K. A., Chapman, P. T., Dalbeth, N., Gow, P. J., Harrison, A. A., Highton, J., Jones, P. B. B., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090142 · Cited by 45
Elevated Serum Level of IL-23 Correlates with Expression of VEGF in Human Colorectal Carcinoma
Ljujić, B., Radosavljevic, G. D., Jovanović, I., Pavlovic, S. M., Zdravkovic, N. S., Milovanović, M., Aćimović, L., Knežević, M., Banković, D., Zdravkovic, D., et al. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.02.009 · Cited by 42
Kageyama, Y., Kobayashi, H., & Kato, N. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0217-6 · Cited by 39
Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patients
Sáfrány, E., Hóbor, R., Jakab, L., Tarr, T., Csongei, V., Járomi, L., Sipeky, C., Valasek, A., Zeher, M., Fust, G., et al. (2010) · Inflammation Research · doi:10.1007/s00011-009-0089-4 · Cited by 24
No association between interleukin 23 receptor gene polymorphisms and systemic lupus erythematosus
Kim, H.-S., Kim, I., Kim, J. O., Bae, J. S., Shin, H. D., & Bae, S. (2009) · Rheumatology International · doi:10.1007/s00296-009-0893-8 · Cited by 21
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis
Gordon, K. B. (2010) · Core evidence · doi:10.2147/ce.s5994 · Cited by 16
Cited by
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A., Zhang, H., McLellan, M., Yau, C., Kandoth, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.033 · Cited by 1,858
Reich, K., Papp, K. A., Blauvelt, A., Tyring, S. K., Sinclair, R., Thaçi, D., Nograles, K., Mehta, A., Cichanowitz, N., Li, Q., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31279-5 · Cited by 569
Inflammatory mediators in the pathogenesis of periodontitis
Yucel-Lindberg, T., & Båge, T. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.8 · Cited by 472
Anti-Inflammatory Activity of Natural Products
Azab, A., Nassar, A., & Azab, A. (2016) · Molecules · doi:10.3390/molecules21101321 · Cited by 462
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity
Minciullo, P. L., Catalano, A., Mandraffino, G., Casciaro, M., Crucitti, A., Maltese, G., Morabito, N., Lasco, A., Gangemi, S., & Basile, G. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0377-3 · Cited by 433
Metadata
- Authors
- Duvallet, E., Semerano, L., Assier, E., Falgarone, G., & Boissier, M.-C.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2011-05-17
- Volume
- 43
- Issue
- 7
- Pages
- 503-511
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W1968893079
- Cited by
- 282
- References
- 56
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.